Literature DB >> 21412765

Cigarette smoking and subtypes of bladder cancer.

Xuejuan Jiang1, J Esteban Castelao, Jian-Min Yuan, Mariana C Stern, David V Conti, Victoria K Cortessis, Malcolm C Pike, Manuela Gago-Dominguez.   

Abstract

There is little information regarding associations between suspected bladder cancer risk factors and tumor subtypes at diagnosis. Some, but not all, studies have found that bladder cancer among smokers is often more invasive than it is among nonsmokers. This population-based case-control study was conducted in Los Angeles, California, involving 1,586 bladder cancer patients and their individually matched controls. Logistic regression was used to conduct separate analyses according to tumor subtypes defined by stage and grade. Cigarette smoking increased risk of both superficial and invasive bladder cancer, but the more advanced the stage, the stronger the effect. The odds ratios associated with regular smokers were 2.2 (95% confidence intervals, 1.8-2.8), 2.7 (2.1-3.6) and 3.7 (2.5-5.5) for low-grade superficial, high-grade superficial and invasive tumors respectively. This pattern was consistently observed regardless of the smoking exposure index under examination. Women had higher risk of invasive bladder cancer than men even they smoked comparable amount of cigarettes as men. There was no gender difference in the association between smoking and risk of low-grade superficial bladder cancer. The heterogeneous effect of cigarette smoking was attenuated among heavy users of NSAIDs. Our results indicate that cigarette smoking was more strongly associated with increased risk of invasive bladder cancer than with low-grade superficial bladder cancer.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412765      PMCID: PMC3210924          DOI: 10.1002/ijc.26068

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

Review 1.  Biology and management of bladder cancer.

Authors:  D Raghavan; W U Shipley; M B Garnick; P J Russell; J P Richie
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

2.  Clinical experience with transitional cell carcinoma of the bladder with special reference to smoking.

Authors:  A A Carpenter
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

3.  The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder.

Authors:  I M Thompson; M Peek; F R Rodriguez
Journal:  J Urol       Date:  1987-03       Impact factor: 7.450

4.  Cigarette smoking and bladder cancer: an epidemiological inquiry in West Yorkshire.

Authors:  R A Cartwright; R Adib; I Appleyard; R W Glashan; B Gray; P A Hamilton-Stewart; M Robinson; D Barham-Hall
Journal:  J Epidemiol Community Health       Date:  1983-12       Impact factor: 3.710

5.  Occupation, smoking, and the risk of high-grade invasive bladder cancer in Missouri.

Authors:  D R Brooks; A C Geller; J Chang; D R Miller
Journal:  Am J Ind Med       Date:  1992       Impact factor: 2.214

6.  Gender- and smoking-related bladder cancer risk.

Authors:  J E Castelao; J M Yuan; P L Skipper; S R Tannenbaum; M Gago-Dominguez; J S Crowder; R K Ross; M C Yu
Journal:  J Natl Cancer Inst       Date:  2001-04-04       Impact factor: 13.506

7.  Genetic susceptibility to distinct bladder cancer subphenotypes.

Authors:  Lin T Guey; Montserrat García-Closas; Cristiane Murta-Nascimento; Josep Lloreta; Laia Palencia; Manolis Kogevinas; Nathaniel Rothman; Gemma Vellalta; M Luz Calle; Gaëlle Marenne; Adonina Tardón; Alfredo Carrato; Reina García-Closas; Consol Serra; Debra T Silverman; Stephen Chanock; Francisco X Real; Núria Malats
Journal:  Eur Urol       Date:  2009-08-12       Impact factor: 20.096

8.  Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.

Authors:  Aditi Hazra; H Barton Grossman; Yong Zhu; Sherry Luo; Margaret R Spitz; Xifeng Wu
Journal:  Genes Chromosomes Cancer       Date:  2004-12       Impact factor: 5.006

9.  The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours.

Authors:  O M Jensen; J Wahrendorf; M Blettner; J B Knudsen; B L Sørensen
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

Review 10.  Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.

Authors:  Erika M Wolff; Gangning Liang; Peter A Jones
Journal:  Nat Clin Pract Urol       Date:  2005-10
View more
  18 in total

1.  Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.

Authors:  Matthew E Nielsen; Angela B Smith; Anne-Marie Meyer; Tzy-Mey Kuo; Seth Tyree; William Y Kim; Matthew I Milowsky; Raj S Pruthi; Robert C Millikan
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

2.  Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Authors:  Yuanyi Wu; Yong Yang
Journal:  Tumour Biol       Date:  2014-02-07

3.  Fluid intake and risk of bladder cancer in the Nurses' Health Studies.

Authors:  Jiachen Zhou; Karl T Kelsey; Edward Giovannucci; Dominique S Michaud
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

4.  Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.

Authors:  Hao Min Li; Baihetiya Azhati; Mulati Rexiati; Wen Guang Wang; Xiao Dong Li; Qiang Liu; Yu-Jie Wang
Journal:  Int Urol Nephrol       Date:  2016-10-20       Impact factor: 2.370

5.  Risk factors for development of primary bladder squamous cell carcinoma.

Authors:  K V Manley; R Hubbard; D Swallow; W Finch; S J Wood; S M Biers
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

6.  Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Michael Rink; Evanguelos Xylinas; Vitaly Margulis; Eugene K Cha; Behfar Ehdaie; Jay D Raman; Felix K Chun; Kazumasa Matsumoto; Yair Lotan; Helena Furberg; Marek Babjuk; Armin Pycha; Christopher G Wood; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

7.  Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.

Authors:  Michael Rink; Helena Furberg; Emily C Zabor; Evanguelos Xylinas; Marko Babjuk; Armin Pycha; Yair Lotan; Pierre I Karakiewicz; Giacomo Novara; Brian D Robinson; Francesco Montorsi; Felix K Chun; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-08-21       Impact factor: 20.096

8.  Does quantification of smoking history correlate with initial bladder tumor grade and stage?

Authors:  Eugene J Pietzak; S Bruce Malkowicz
Journal:  Curr Urol Rep       Date:  2014-07       Impact factor: 3.092

9.  Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer: A Pooled Analysis of 15 Case-Control Studies.

Authors:  Frits H M van Osch; Jelle Vlaanderen; Sylvia H J Jochems; Cristina Bosetti; Jerry Polesel; Stefano Porru; Angela Carta; Klaus Golka; Xuejuan Jiang; Mariana C Stern; Wei-De Zhong; Eliane Kellen; Hermann Pohlabeln; Li Tang; James Marshall; Gunnar Steineck; Margaret R Karagas; Kenneth C Johnson; Zuo-Feng Zhang; Jack A Taylor; Carlo La Vecchia; Richard T Bryan; Frederik J van Schooten; Anke Wesselius; Maurice P Zeegers
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

10.  An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.

Authors:  Changwei Ji; Zhao Liu; Huimei Chen; Hongqian Guo; Changjian Liu
Journal:  BMC Cancer       Date:  2012-08-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.